Mouse Anti-IGHM Recombinant Antibody (SPM188) (CBMAB-I1091-YY)
Basic Information
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268).
IgM antibodies play an important role in primary defense mechanisms. They have been shown to be involved in early recognition of external invaders like bacteria and viruses, cellular waste and modified self, as well as in recognition and elimination of precancerous and cancerous lesions. The membrane-bound form is found in the majority of normal B-cells alongside with IgD. Membrane-bound IgM induces the phosphorylation of CD79A and CD79B by the Src family of protein tyrosine kinases. It may cause death of cells by apoptosis. It is also found in soluble form, which represents about 30% of the total serum immunoglobulins where it is found almost exclusively as a homopentamer. After the antigen binds to the B-cell receptor, the secreted form is secreted in large amounts (PubMed:3137579, PubMed:16895553).
Antibacterial humoral response Source: UniProtKB
B cell receptor signaling pathway Source: GO_Central
Complement activation, classical pathway Source: GO_Central
Defense response to bacterium Source: GO_Central
Defense response to Gram-negative bacterium Source: UniProtKB
Innate immune response Source: UniProtKB
Phagocytosis, engulfment Source: GO_Central
Phagocytosis, recognition Source: GO_Central
Positive regulation of B cell activation Source: GO_Central
Isoform 2: Cell membrane
A primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life.
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon
Submit a review
Loading...
Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols
Related Products
Mouse Anti-IGHM Recombinant Antibody (CBYY-I0083) (CAT#: CBMAB-I0211-YY)
Mouse Anti-IGHM Recombinant Antibody (R1/69) (CAT#: CBMAB-I0994-YY)
Mouse Anti-IGHM Recombinant Antibody (CBYY-I0488) (CAT#: CBMAB-I1135-YY)
Mouse Anti-IGHM Recombinant Antibody (ICO-30) (CAT#: CBMAB-I0215-YY)
Mouse Anti-IGHM Recombinant Antibody (CBYY-I0886) (CAT#: CBMAB-I2054-YY)
Rat Anti-IGHM Recombinant Antibody (II/41) (CAT#: CBMAB-I0216-YY)
Mouse Anti-IGHM Recombinant Antibody (CBT2740) (CAT#: V2LY-0625-LY670)
Mouse Anti-IGHM Recombinant Antibody (CBYY-I0481) (CAT#: CBMAB-I1125-YY)
Rat Anti-IGHM Recombinant Antibody (CBYY-I0404) (CAT#: CBMAB-I1001-YY)
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us

